Palonosetron

FDA Approved: * November 21, 2017
Pharm Company: * FRESENIUS KABI USA
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Palonosetron Overview

Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). It is used for the control of delayed CINV—nausea and vomiting and there are tentative data to suggest that it may be more effective than granisetron.[1] Palonosetron is administered intravenously,[2] or as a single oral capsule.[3] It has a longer duration of action than other 5-HT3 antagon...

Read more Palonosetron Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Palonosetron

Recent Palonosetron Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Palonosetron
  • Capsule: 0.5mg
  • Injection: 0.075mg/1.5ml (0.05mg/ml), 0.25mg/5ml, 0.25mg/5ml (0.05mg/ml)
  • Solution: 0.25mg/5ml, 0.25mg/5ml (0.05mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Palonosetron: (25 results)

Showing the first 20, Sorted by National Drug Code
  • 0143-9513 Palonosetron Hydrochloride .25 mg/2ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0409-2504 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Hospira, Inc.
  • 0703-4094 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0781-3312 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Sandoz Inc
  • 0781-3415 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Sandoz Inc
  • 16714-834 Palonosetron .05 mg/ml Intravenous Injection, Solution by Northstar Rx LLC
  • 16729-365 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection by Accord Healthcare, Inc.
  • 23155-356 Palonosetron Hydrochloride .05 mg/ml Intravenous Injection by Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.
  • 25021-783 Palonosetron Hydrochloride .05 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 25021-788 Palonosetron Hydrochloride .05 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 36000-326 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection by Baxter Healthcare Corporation
  • 50742-485 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection by Ingenus Pharmaceuticals, LLC
  • 55111-694 Palonosetron .05 mg/ml Intravenous Injection, Solution by Dr.reddy's Laboratories Limited
  • 55150-186 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Auromedics Pharma LLC
  • 60505-6193 Palonosetron .25 mg/5ml Intravenous Injection by Apotex Corp.
  • 63323-673 Palonosetron .25 mg/5ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
  • 63323-942 Palonosetron .25 mg/5ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
  • 67184-0514 Palonosetron .25 mg/5ml Intravenous Injection by Qilu Pharmaceutical Co., Ltd.
  • 67184-0515 Palonosetron .075 mg/1.5ml Intravenous Injection by Qilu Pharmaceutical Co., Ltd.
  • 67457-317 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 5 more results ...

Other drugs which contain Palonosetron or a similar ingredient: (3 results)